Variations in the Use of Blood Transfusion in Patients with Coronary Artery Disease

Login or register to view PDF.
Login or register to view eJournal.

Blood transfusions are frequently given to patients to treat low hemoglobin levels in the setting of non-ST-segment elevation acute coronary syndromes, percutaneous coronary intervention, and coronary artery bypass grafting. Evidence suggests that blood transfusion therapy in the setting of ischemic heart disease is associated with an increased risk for morbidity and mortality; however, there are no randomized clinical trials concerning transfusion strategies in ischemic heart disease. The evidence to date is observational and subject to confounding influences. This lack of definitive data has led to wide variations in transfusion practice in both the US and the international medical community. The purpose of this article is to examine the current literature concerning the transfusion practice of whole or packed red blood cells in the US and internationally in patients with ischemic heart disease. We propose that a prospective, randomized, controlled trial of transfusion strategies in ischemic heart disease is needed to determine the role of transfusion in this patient population.

Antonio Gutierrez, MD, has no conflicts of interest to declare. Sunil V Rao, MD, FACC, FSCAI, is a consultant for sanofi-aventis, Bristol Myers Squibb, and The Medicines Company, and receives research funding from Cordis Corporation, Momenta Pharmaceuticals, and Portola Pharmaceuticals.
Antonio Gutierrez, MD, Box 31022/DUMC, Durham, NC 27710. E:
Received date
08 September 2008
Accepted date
18 November 2008
US Cardiology - Volume 6 Issue 1;2009:6(1):89-91
Antonio Gutierrez, MD, Box 31022/DUMC, Durham, NC 27710. E:
PREMIUM CONTENTArticles are free-to-download for registered users only. It's free to register and takes less than 1 minute. Please either Login or register to read in HTML & eJournal format or to download our PDFs. *Your details will only be used internally to learn more about our audience and will never be passed on.

Vegan Heart – The Blog of Heather Shenkman MD, FACC

  • 19 November 2014
    I had an awesome triathlon season -- three Ironman 70.3 events, moving from top 27%, to top 23%, to top 20% in my age group.After my nearly ten years...
  • 28 October 2014
    Last week, I attended the annual meeting of the American College of Lifestyle Medicine.  Not only was it an opportunity to hear some of my...